4-(azidophenylacetyl)-2,4-diaminobutyric acid(A1)- insulin

Subscribe to Selected New Research on 4-(azidophenylacetyl)-2,4-diaminobutyric acid(A1)- insulin

0 relevant articles (0 outcomes, 0 trials/studies) found for this Bio-Agent

Also Known As:

insulin, 4-(azidophenylacetyl)-2,4-diaminobutyric acid(A1)-; A1-4-azidophenylacetyl-2,4-diaminobutyric acid insulin; APA-DAB-insulin; Insulin, 1A-(N4-((4-azidophenyl)acetyl)-D-2,4-diaminobutanoic acid)-8A-L-threonine-10A-L-isoleucine-

Bio-Agent Context: Research Results

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>